Preclinical Progress of Subunit and Live Attenuated <i>Mycobacterium tuberculosis</i> Vaccines: A Review following the First in Human Efficacy Trial
Tuberculosis (TB) is the global leading cause of death from an infectious agent with approximately 10 million new cases of TB and 1.45 million deaths in 2018. Bacille Calmette-Guérin (BCG) remains the only approved vaccine for <i>Mycobacterium tuberculosis</i> (<i>M. tb</i>,...
Saved in:
Main Authors: | Jacqueline Watt (Author), Jun Liu (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antimicrobial Peptide against <i>Mycobacterium Tuberculosis</i> That Activates Autophagy Is an Effective Treatment for Tuberculosis
by: Erika A. Peláez Coyotl, et al.
Published: (2020) -
Mechanisms of a <i>Mycobacterium tuberculosis</i> Active Peptide
by: Komal Umashankar Rao, et al.
Published: (2023) -
Perchlozone Resistance in Clinical Isolates of <i>Mycobacterium tuberculosis</i>
by: Anastasia Ushtanit, et al.
Published: (2023) -
Fluoroquinolone Derivatives in the Treatment of <i>Mycobacterium tuberculosis</i> Infection
by: João Pedro Pais, et al.
Published: (2022) -
Multi-stage subunit vaccines against Mycobacterium tuberculosis: an alternative to the BCG vaccine or a BCG-prime boost?
by: Farzad Khademi, et al.
Published: (2018)